These findings collectively indicated that α9 nAChR modulated ferroptosis suppression in TNBC mainly through dually promoting SLC7A11/GPX4 and Keap1/Nrf2/HO1 signaling, ultimately maintaining tumor cell survival. The gene discussed is HMOX1; the disease is neoplasm.